NEW YORK (GenomeWeb) – Qiagen has received a warning letter from the US Food and Drug Administration regarding its QuantiFeron-TB Gold blood test for tuberculosis diagnosis. The agency said there have been multiple complaints about the test's high rate of false positives and that it has been misbranded, among other violations of federal law.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.